Autosomal recessive non-syndromic intellectual disability
diseaseOn this page
Also known as AR-NSIDautosomal recessive intellectual disabilityintellectual disability, autosomal recessivemental retardation, autosomal recessivenon-syndromic intellectual disability, autosomal recessiveNS-ARID
Summary
Autosomal recessive non-syndromic intellectual disability (MONDO:0019502) is a disease (an umbrella term covering 68 Mondo subtypes) with 51 cohort genes. The dominant Reactome pathway is Maturation of spike protein (3 cohort genes).
At a glance
- Umbrella term: 68 Mondo subtypes
- Cohort genes: 51
- ClinVar variants: 9
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | autosomal recessive non-syndromic intellectual disability |
| Mondo ID | MONDO:0019502 |
| OMIM | 249500 |
| Orphanet | 88616 |
| DOID | DOID:0060308 |
| UMLS | C5680181 |
| MedGen | 1826073 |
| GARD | 0018643 |
| Is cancer (heuristic) | no |
Also known as: AR-NSID · autosomal recessive intellectual disability · autosomal recessive non-syndromic intellectual disability · intellectual disability, autosomal recessive · mental retardation, autosomal recessive · non-syndromic intellectual disability, autosomal recessive · NS-ARID
Data availability: 9 ClinVar variants · 44 GenCC gene-disease records · 2 cell lines.
Disease family
An umbrella term covering 68 Mondo subtypes.
Classification path: disease › human disease › disease by body system or component › nervous system disorder › neurodevelopmental disorder › intellectual disability › non-syndromic intellectual disability › autosomal recessive non-syndromic intellectual disability
Related subtypes (2): autosomal dominant non-syndromic intellectual disability, non-syndromic X-linked intellectual disability
Subtypes (68): intellectual disability, autosomal recessive 1, intellectual disability, autosomal recessive 2, intellectual disability, autosomal recessive 3, intellectual disability, autosomal recessive 12, intellectual disability, autosomal recessive 5, intellectual disability, autosomal recessive 6, intellectual disability, autosomal recessive 7, intellectual disability, autosomal recessive 9, intellectual disability, autosomal recessive 10, intellectual disability, autosomal recessive 11, intellectual disability, autosomal recessive 4, intellectual disability, autosomal recessive 13, intellectual disability, autosomal recessive 14, Rafiq syndrome, intellectual disability, autosomal recessive 16, intellectual disability, autosomal recessive 18, intellectual disability, autosomal recessive 31, intellectual disability, autosomal recessive 29, intellectual disability, autosomal recessive 27, intellectual disability, autosomal recessive 33, intellectual disability, autosomal recessive 30, intellectual disability, autosomal recessive 19, intellectual disability, autosomal recessive 23, intellectual disability, autosomal recessive 24, intellectual disability, autosomal recessive 25, intellectual disability, autosomal recessive 28, intellectual disability, autosomal recessive 34, intellectual disability, autosomal recessive 42, intellectual disability, autosomal recessive 43, intellectual disability, autosomal recessive 44, intellectual disability, autosomal recessive 45, intellectual disability, autosomal recessive 46, intellectual disability, autosomal recessive 47, Al-Raqad syndrome, intellectual disability, autosomal recessive 50, intellectual disability, autosomal recessive 51, intellectual disability, autosomal recessive 52, intellectual disability, autosomal recessive 54, intellectual disability, autosomal recessive 56, intellectual developmental disorder, autosomal recessive 74, intellectual disability, autosomal recessive 57, intellectual disability, autosomal recessive 58, intellectual disability, autosomal recessive 59, pontocerebellar hypoplasia type 1, intellectual disability, autosomal recessive 64, intellectual disability, autosomal recessive 65, intellectual developmental disorder, autosomal recessive 73, intellectual developmental disorder, autosomal recessive 75, with neuropsychiatric features and variant lissencephaly, intellectual disability, autosomal recessive 61, intellectual developmental disorder, autosomal recessive 76, intellectual developmental disorder, autosomal recessive 77, intellectual disability, autosomal recessive 66, intellectual developmental disorder, autosomal recessive 67, intellectual developmental disorder, autosomal recessive 68, intellectual developmental disorder, autosomal recessive 69, intellectual developmental disorder, autosomal recessive 70, intellectual developmental disorder, autosomal recessive 71, intellectual developmental disorder, autosomal recessive 72, glycosylphosphatidylinositol biosynthesis defect 16, intellectual disability, autosomal recessive 60, intellectual disability, autosomal recessive 63, adenosine kinase deficiency, intellectual developmental disorder, autosomal recessive 78, intellectual developmental disorder, autosomal recessive 79, intellectual developmental disorder, autosomal recessive 80, with variant lissencephaly, intellectual developmental disorder, autosomal recessive 81, intellectual developmental disorder, autosomal recessive 82, intellectual developmental disorder, autosomal recessive 83
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
ClinVar germline variants
9 retrieved; paginated sample, class counts are floors:
4 pathogenic, 2 pathogenic/likely pathogenic, 2 uncertain significance, 1 likely pathogenic
| ClinVar | Variant (HGVS) | Gene | Classification | Review |
|---|---|---|---|---|
| 1699097 | NM_017721.5(CC2D1A):c.2347C>T (p.Arg783Ter) | CC2D1A | Pathogenic | criteria provided, single submitter |
| 599374 | NM_001130053.5(EEF1D):c.948G>A (p.Trp316Ter) | EEF1D | Pathogenic | no assertion criteria provided |
| 375705 | NM_182548.4(LHFPL5):c.575T>C (p.Leu192Pro) | LHFPL5 | Pathogenic | criteria provided, single submitter |
| 1030591 | NM_017755.6(NSUN2):c.1165C>T (p.Arg389Ter) | NSUN2 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1203937 | NM_017755.6(NSUN2):c.790C>T (p.Arg264Ter) | NSUN2 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts |
| 1683498 | NM_001160372.4(TRAPPC9):c.1994dup (p.Val666fs) | TRAPPC9 | Pathogenic | no assertion criteria provided |
| 3067138 | NM_021937.5(EEFSEC):c.1169A>C (p.Asp390Ala) | EEFSEC | Likely pathogenic | criteria provided, single submitter |
| 599375 | NM_001100878.2(MROH6):c.1904A>T (p.Asn635Ile) | MROH6 | Uncertain significance | no assertion criteria provided |
| 599376 | NC_000008.11:g.144464447G>T | ZFTRAF1 | Uncertain significance | no assertion criteria provided |
Genes & proteins
Mendelian disease overlap and somatic drivers
GenCC: 242 · Orphanet: 59 · OMIM-shared: 0 · Dual-evidence (GWAS+Mendelian): 0
GenCC gene–disease validity (cohort genes)
the Disease column is the GenCC-asserted condition — a cohort gene’s strongest validity may be for a related predisposition syndrome.
| Gene | Classification | Inheritance | Disease | Records |
|---|---|---|---|---|
| ALKBH8 | Definitive | Autosomal recessive | intellectual developmental disorder, autosomal recessive 71 | 5 |
| CC2D1A | Definitive | Autosomal recessive | intellectual disability, autosomal recessive 3 | 5 |
| GRIK2 | Definitive | Autosomal recessive | intellectual disability, autosomal recessive 6 | 8 |
| MED25 | Definitive | Autosomal recessive | congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome | 7 |
| MED9 | Definitive | Autosomal recessive | congenital cataract-microcephaly-nevus flammeus simplex-severe intellectual disability syndrome | 7 |
| METTL23 | Definitive | Autosomal recessive | intellectual disability, autosomal recessive 44 | 5 |
| PRSS12 | Definitive | Autosomal recessive | intellectual disability, autosomal recessive 1 | 5 |
| RSRC1 | Definitive | Autosomal recessive | intellectual developmental disorder, autosomal recessive 70 | 5 |
| TRAPPC9 | Definitive | Autosomal recessive | intellectual disability, autosomal recessive 13 | 6 |
| TUSC3 | Definitive | Autosomal recessive | intellectual disability | 5 |
| CRADD | Strong | Autosomal recessive | intellectual disability, autosomal recessive 34 | 3 |
| FBXO31 | Strong | Autosomal recessive | intellectual disability, autosomal recessive | 6 |
| FBXO5 | Strong | Autosomal recessive | intellectual disability, autosomal recessive | 6 |
| FMN2 | Strong | Autosomal recessive | intellectual disability, autosomal recessive 47 | 5 |
| HNMT | Strong | Autosomal recessive | intellectual disability, autosomal recessive 51 | 4 |
| IQSEC1 | Strong | Autosomal recessive | intellectual developmental disorder with short stature and behavioral abnormalities | 6 |
| KDM5B | Strong | Autosomal recessive | intellectual disability, autosomal recessive 65 | 5 |
| LINS1 | Strong | Autosomal recessive | intellectual disability, autosomal recessive 27 | 4 |
| MBOAT7 | Strong | Autosomal recessive | intellectual disability, autosomal recessive 57 | 5 |
| MED23 | Strong | Autosomal recessive | intellectual disability, autosomal recessive 18 | 6 |
| NDST1 | Strong | Autosomal recessive | intellectual disability, autosomal recessive 46 | 4 |
| NSUN2 | Strong | Autosomal recessive | intellectual disability, autosomal recessive 5 | 7 |
| PGAP1 | Strong | Autosomal recessive | intellectual disability, autosomal recessive 42 | 5 |
| SLC45A1 | Strong | Autosomal recessive | intellectual developmental disorder with neuropsychiatric features | 5 |
| ST3GAL3 | Strong | Autosomal recessive | intellectual disability, autosomal recessive 12 | 7 |
| WASHC4 | Strong | Autosomal recessive | intellectual disability, autosomal recessive 43 | 4 |
| LMAN2L | Moderate | Autosomal recessive | intellectual disability, autosomal recessive 52 | 8 |
| TNIK | Moderate | Autosomal recessive | intellectual disability, autosomal recessive 54 | 5 |
| ZC3H14 | Moderate | Autosomal recessive | intellectual disability, autosomal recessive 56 | 4 |
| AIMP1 | Supportive | Autosomal recessive | autosomal recessive non-syndromic intellectual disability | 6 |
Orphanet rare-disease linkage (cohort genes)
| Gene | Orphanet ID | Rare disease |
|---|---|---|
| NSUN2 | Orphanet:235 | Dubowitz syndrome |
| NSUN2 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| CC2D1A | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| TRAPPC9 | Orphanet:352530 | Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome |
| TRAPPC9 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| CLIP1 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| SARS1 | Orphanet:2512 | Autosomal recessive primary microcephaly |
| SARS1 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| AIMP1 | Orphanet:280293 | Pelizaeus-Merzbacher-like disease due to AIMP1 mutation |
| AIMP1 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| ST3GAL3 | Orphanet:697734 | ST3GAL3-CDG |
| SLC12A2 | Orphanet:633021 | SLC12A2-related autosomal recessive neonatal-developmental delay-intellectual disability-feeding difficulty-sensorineural deafness syndrome |
| SLC12A2 | Orphanet:633024 | SLC12A2-related autosomal dominant infantile-developmental delay-intellectual disability-sensorineural deafness syndrome |
| UBE4A | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| EZR | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| FRRS1L | Orphanet:725 | Developmental and epileptic encephalopathy with spike-wave activation in sleep |
| FRRS1L | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| FMN2 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| MBOAT7 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| FBXO31 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| NCDN | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| SLC45A1 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| KDM5B | Orphanet:178469 | Autosomal dominant non-syndromic intellectual disability |
| KDM5B | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| LMAN2L | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| TTC5 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| ZC3H14 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| CRADD | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| MED23 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| RSRC1 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| ALKBH8 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| UFSP2 | Orphanet:2114 | Hip dysplasia, Beukes type |
| UFSP2 | Orphanet:442835 | Non-specific early-onset epileptic encephalopathy |
| PGAP1 | Orphanet:401820 | Autosomal recessive spastic paraplegia type 67 |
| PGAP1 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| EDC3 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| METTL23 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| B3GALNT2 | Orphanet:588 | Muscle-eye-brain disease |
| B3GALNT2 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| B3GALNT2 | Orphanet:899 | Walker-Warburg syndrome |
| MED25 | Orphanet:464738 | Basel-Vanagaite-Smirin-Yosef syndrome |
| MED25 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| IQSEC1 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| WASHC4 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| DCPS | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| CRBN | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| TUSC3 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| TNIK | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| LINS1 | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
| TECR | Orphanet:88616 | Autosomal recessive non-syndromic intellectual disability |
Cohort genes → proteins
51 cohort genes, 51 distinct canonical proteins.
Evidence partition
| Subset | Genes |
|---|---|
| multi_evidence | 51 |
Cohort genes (full)
| Symbol | HGNC | Ensembl | UniProt | Name | Evidence |
|---|---|---|---|---|---|
| NSUN2 | HGNC:25994 | ENSG00000037474 | Q08J23 | RNA cytosine C(5)-methyltransferase NSUN2 | gencc,clinvar |
| CC2D1A | HGNC:30237 | ENSG00000132024 | Q6P1N0 | Coiled-coil and C2 domain-containing protein 1A | gencc,clinvar |
| TRAPPC9 | HGNC:30832 | ENSG00000167632 | Q96Q05 | Trafficking protein particle complex subunit 9 | gencc,clinvar |
| CLIP1 | HGNC:10461 | ENSG00000130779 | P30622 | CAP-Gly domain-containing linker protein 1 | gencc |
| SARS1 | HGNC:10537 | ENSG00000031698 | P49591 | Serine–tRNA ligase, cytoplasmic | gencc |
| AIMP1 | HGNC:10648 | ENSG00000164022 | Q12904 | Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 | gencc |
| ST3GAL3 | HGNC:10866 | ENSG00000126091 | Q11203 | CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase | gencc |
| SLC12A2 | HGNC:10911 | ENSG00000064651 | P55011 | Solute carrier family 12 member 2 | gencc |
| UBE4A | HGNC:12499 | ENSG00000110344 | Q14139 | Ubiquitin conjugation factor E4 A | gencc |
| EZR | HGNC:12691 | ENSG00000092820 | P15311 | Ezrin | gencc |
| FBXO5 | HGNC:13584 | ENSG00000112029 | Q9UKT4 | F-box only protein 5 | gencc |
| FRRS1L | HGNC:1362 | ENSG00000260230 | Q9P0K9 | DOMON domain-containing protein FRRS1L | gencc |
| FMN2 | HGNC:14074 | ENSG00000155816 | Q9NZ56 | Formin-2 | gencc |
| MBOAT7 | HGNC:15505 | ENSG00000125505 | Q96N66 | Membrane-bound acylglycerophosphatidylinositol O-acyltransferase MBOAT7 | gencc |
| FBXO31 | HGNC:16510 | ENSG00000103264 | Q5XUX0 | F-box only protein 31 | gencc |
| NCDN | HGNC:17597 | ENSG00000020129 | Q9UBB6 | Neurochondrin | gencc |
| SLC45A1 | HGNC:17939 | ENSG00000162426 | Q9Y2W3 | Proton-associated sugar transporter A | gencc |
| KDM5B | HGNC:18039 | ENSG00000117139 | Q9UGL1 | Lysine-specific demethylase 5B | gencc |
| LMAN2L | HGNC:19263 | ENSG00000114988 | Q9H0V9 | VIP36-like protein | gencc |
| TTC5 | HGNC:19274 | ENSG00000136319 | Q8N0Z6 | Tetratricopeptide repeat protein 5 | gencc |
| ZC3H14 | HGNC:20509 | ENSG00000100722 | Q6PJT7 | Zinc finger CCCH domain-containing protein 14 | gencc |
| CRADD | HGNC:2340 | ENSG00000169372 | P78560 | Death domain-containing protein CRADD | gencc |
| MED23 | HGNC:2372 | ENSG00000112282 | Q9ULK4 | Mediator of RNA polymerase II transcription subunit 23 | gencc |
| RSRC1 | HGNC:24152 | ENSG00000174891 | Q96IZ7 | Serine/Arginine-related protein 53 | gencc |
| ALKBH8 | HGNC:25189 | ENSG00000137760 | Q96BT7 | tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ALKBH8 | gencc |
| MED9 | HGNC:25487 | ENSG00000141026 | Q9NWA0 | Mediator of RNA polymerase II transcription subunit 9 | gencc |
| UFSP2 | HGNC:25640 | ENSG00000109775 | Q9NUQ7 | Ufm1-specific protease 2 | gencc |
| PGAP1 | HGNC:25712 | ENSG00000197121 | Q75T13 | GPI inositol-deacylase | gencc |
| EDC3 | HGNC:26114 | ENSG00000179151 | Q96F86 | Enhancer of mRNA-decapping protein 3 | gencc |
| METTL23 | HGNC:26988 | ENSG00000181038 | Q86XA0 | Histone-arginine methyltransferase METTL23 | gencc |
| B3GALNT2 | HGNC:28596 | ENSG00000162885 | Q8NCR0 | UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 | gencc |
| MED25 | HGNC:28845 | ENSG00000104973 | Q71SY5 | Mediator of RNA polymerase II transcription subunit 25 | gencc |
| IQSEC1 | HGNC:29112 | ENSG00000144711 | Q6DN90 | IQ motif and SEC7 domain-containing protein 1 | gencc |
| WASHC4 | HGNC:29174 | ENSG00000136051 | Q2M389 | WASH complex subunit 4 | gencc |
| DCPS | HGNC:29812 | ENSG00000110063 | Q96C86 | m7GpppX diphosphatase | gencc |
| CRBN | HGNC:30185 | ENSG00000113851 | Q96SW2 | Protein cereblon | gencc |
| TUSC3 | HGNC:30242 | ENSG00000104723 | Q13454 | Dolichyl-diphosphooligosaccharide–protein glycosyltransferase subunit TUSC3 | gencc |
| TNIK | HGNC:30765 | ENSG00000154310 | Q9UKE5 | TRAF2 and NCK-interacting protein kinase | gencc |
| LINS1 | HGNC:30922 | ENSG00000140471 | Q8NG48 | Protein Lines homolog 1 | gencc |
| TECR | HGNC:4551 | ENSG00000099797 | Q9NZ01 | Very-long-chain enoyl-CoA reductase | gencc |
| GRIK2 | HGNC:4580 | ENSG00000164418 | Q13002 | Glutamate receptor ionotropic, kainate 2 | gencc |
| HNMT | HGNC:5028 | ENSG00000150540 | P50135 | Histamine N-methyltransferase | gencc |
| MAN1B1 | HGNC:6823 | ENSG00000177239 | Q9UKM7 | Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase | gencc |
| NDST1 | HGNC:7680 | ENSG00000070614 | P52848 | Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 | gencc |
| PIGC | HGNC:8960 | ENSG00000135845 | Q92535 | Phosphatidylinositol N-acetylglucosaminyltransferase subunit C | gencc |
| PRSS12 | HGNC:9477 | ENSG00000164099 | P56730 | Neurotrypsin | gencc |
| ZFTRAF1 | HGNC:17806 | ENSG00000187954 | P0DTL6 | Zinc finger TRAF-type-containing protein 1 | clinvar |
| LHFPL5 | HGNC:21253 | ENSG00000197753 | Q8TAF8 | LHFPL tetraspan subfamily member 5 protein | clinvar |
| EEFSEC | HGNC:24614 | ENSG00000132394 | P57772 | Selenocysteine-specific elongation factor | clinvar |
| MROH6 | HGNC:27814 | ENSG00000204839 | A6NGR9 | Maestro heat-like repeat-containing protein family member 6 | clinvar |
Cohort function summary
Lead sentence per gene, UniProt-curated.
| Symbol | Protein name | Function (lead sentence) |
|---|---|---|
| NSUN2 | RNA cytosine C(5)-methyltransferase NSUN2 | RNA cytosine C(5)-methyltransferase that methylates cytosine to 5-methylcytosine (m5C) in various RNAs, such as tRNAs, mRNAs and some long non-coding RNAs (lncRNAs). |
| CC2D1A | Coiled-coil and C2 domain-containing protein 1A | Transcription factor that binds specifically to the DRE (dual repressor element) and represses HTR1A gene transcription in neuronal cells. |
| TRAPPC9 | Trafficking protein particle complex subunit 9 | Functions as an activator of NF-kappa-B through increased phosphorylation of the IKK complex. |
| CLIP1 | CAP-Gly domain-containing linker protein 1 | Binds to the plus end of microtubules and regulates the dynamics of the microtubule cytoskeleton. |
| SARS1 | Serine–tRNA ligase, cytoplasmic | Catalyzes the attachment of serine to tRNA(Ser) in a two-step reaction: serine is first activated by ATP to form Ser-AMP and then transferred to the acceptor end of tRNA(Ser). |
| AIMP1 | Aminoacyl tRNA synthase complex-interacting multifunctional protein 1 | Non-catalytic component of the multisynthase complex. |
| ST3GAL3 | CMP-N-acetylneuraminate-beta-1,4-galactoside alpha-2,3-sialyltransferase | Catalyzes the formation of the NeuAc-alpha-2,3-Gal-beta-1,4-GlcNAc-, NeuAc-alpha-2,3-Gal-beta-1,3-GlcNAc- and NeuAc-alpha-2,3-Gal-beta-1,3-GalNAc- sequences found in terminal carbohydrate groups of glycoproteins and glycolipids. |
| SLC12A2 | Solute carrier family 12 member 2 | Cation-chloride cotransporter which mediates the electroneutral transport of chloride, potassium and/or sodium ions across the membrane. |
| UBE4A | Ubiquitin conjugation factor E4 A | Ubiquitin-protein ligase that probably functions as an E3 ligase in conjunction with specific E1 and E2 ligases. |
| EZR | Ezrin | Probably involved in connections of major cytoskeletal structures to the plasma membrane. |
| FBXO5 | F-box only protein 5 | Regulator of APC activity during mitotic and meiotic cell cycle. |
| FRRS1L | DOMON domain-containing protein FRRS1L | Important modulator of glutamate signaling pathway. |
| FMN2 | Formin-2 | Actin-binding protein that is involved in actin cytoskeleton assembly and reorganization. |
| MBOAT7 | Membrane-bound acylglycerophosphatidylinositol O-acyltransferase MBOAT7 | Acyltransferase which catalyzes the transfer of an acyl group from an acyl-CoA to a lysophosphatidylinositol (1-acylglycerophosphatidylinositol or LPI) leading to the production of a phosphatidylinositol (1,2-diacyl-sn-glycero-3-phosphoino… |
| FBXO31 | F-box only protein 31 | Substrate-recognition component of the SCF(FBXO31) protein ligase complex, which specifically mediates the ubiquitination of proteins amidated at their C-terminus in response to oxidative stress, leading to their degradation by the proteas… |
| NCDN | Neurochondrin | Probably involved in signal transduction in the nervous system, via increasing cell surface localization of GRM5/mGluR5 and positively regulating its signaling. |
| SLC45A1 | Proton-associated sugar transporter A | Proton-associated glucose transporter in the brain. |
| KDM5B | Lysine-specific demethylase 5B | Histone demethylase that demethylates ‘Lys-4’ of histone H3, thereby playing a central role in histone code. |
| LMAN2L | VIP36-like protein | May be involved in the regulation of export from the endoplasmic reticulum of a subset of glycoproteins. |
| TTC5 | Tetratricopeptide repeat protein 5 | Cofactor involved in the regulation of various cellular mechanisms such as actin regulation, autophagy, chromatin regulation and DNA repair. |
| ZC3H14 | Zinc finger CCCH domain-containing protein 14 | RNA-binding protein involved in the biogenesis of circular RNAs (circRNAs), which are produced by back-splicing circularization of pre-mRNAs. |
| CRADD | Death domain-containing protein CRADD | Adapter protein that associates with PIDD1 and the caspase CASP2 to form the PIDDosome, a complex that activates CASP2 and triggers apoptosis. |
| MED23 | Mediator of RNA polymerase II transcription subunit 23 | Required for transcriptional activation subsequent to the assembly of the pre-initiation complex. |
| RSRC1 | Serine/Arginine-related protein 53 | Has a role in alternative splicing and transcription regulation. |
| ALKBH8 | tRNA (carboxymethyluridine(34)-5-O)-methyltransferase ALKBH8 | Catalyzes the methylation of 5-carboxymethyl uridine to 5-methylcarboxymethyl uridine at the wobble position of the anticodon loop in tRNA via its methyltransferase domain. |
| MED9 | Mediator of RNA polymerase II transcription subunit 9 | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. |
| UFSP2 | Ufm1-specific protease 2 | Thiol-dependent isopeptidase that specifically cleaves UFM1, a ubiquitin-like modifier protein, from conjugated proteins, such as CD274/PD-L1, CYB5R3, DDRGK1, MRE11, RPL26/uL24, TRIP4 and RPL26/uL24. |
| PGAP1 | GPI inositol-deacylase | GPI inositol-deacylase that catalyzes the remove of the acyl chain linked to the 2-OH position of inositol ring from the GPI-anchored protein (GPI-AP) in the endoplasmic reticulum. |
| EDC3 | Enhancer of mRNA-decapping protein 3 | Binds single-stranded RNA. |
| METTL23 | Histone-arginine methyltransferase METTL23 | Histone methyltransferase that dimethylates histone H3 at ‘Arg-17’, forming asymmetric dimethylarginine (H3R17me2a), leading to activate transcription via chromatin remodeling. |
| B3GALNT2 | UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 2 | Beta-1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAc-beta-1-3GlcNAc, on N- and O-glycans. |
| MED25 | Mediator of RNA polymerase II transcription subunit 25 | Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. |
| IQSEC1 | IQ motif and SEC7 domain-containing protein 1 | Guanine nucleotide exchange factor for ARF1 and ARF6. |
| WASHC4 | WASH complex subunit 4 | Acts as a component of the WASH core complex that functions as a nucleation-promoting factor (NPF) at the surface of endosomes, where it recruits and activates the Arp2/3 complex to induce actin polymerization, playing a key role in the fi… |
| DCPS | m7GpppX diphosphatase | Decapping scavenger enzyme that catalyzes the cleavage of a residual cap structure following the degradation of mRNAs by the 3’->5’ exosome-mediated mRNA decay pathway. |
| CRBN | Protein cereblon | Substrate recognition component of a DCX (DDB1-CUL4-X-box) E3 protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins, such as MEIS2, ILF2 or GLUL. |
| TUSC3 | Dolichyl-diphosphooligosaccharide–protein glycosyltransferase subunit TUSC3 | Acts as accessory component of the N-oligosaccharyl transferase (OST) complex which catalyzes the transfer of a high mannose oligosaccharide from a lipid-linked oligosaccharide donor to an asparagine residue within an Asn-X-Ser/Thr consens… |
| TNIK | TRAF2 and NCK-interacting protein kinase | Serine/threonine kinase that acts as an essential activator of the Wnt signaling pathway. |
| TECR | Very-long-chain enoyl-CoA reductase | Involved in both the production of very long-chain fatty acids for sphingolipid synthesis and the degradation of the sphingosine moiety in sphingolipids through the sphingosine 1-phosphate metabolic pathway. |
| GRIK2 | Glutamate receptor ionotropic, kainate 2 | Ionotropic glutamate receptor that functions as a cation-permeable ligand-gated ion channel, gated by L-glutamate and the glutamatergic agonist kainic acid. |
| HNMT | Histamine N-methyltransferase | Inactivates histamine by N-methylation. |
| MAN1B1 | Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase | Involved in glycoprotein quality control targeting of misfolded glycoproteins for degradation. |
| NDST1 | Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1 | Essential bifunctional enzyme that catalyzes both the N-deacetylation and the N-sulfation of glucosamine (GlcNAc) of the glycosaminoglycan in heparan sulfate. |
| PIGC | Phosphatidylinositol N-acetylglucosaminyltransferase subunit C | Part of the glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex that catalyzes the transfer of N-acetylglucosamine from UDP-N-acetylglucosamine to phosphatidylinositol and participates in the first step of GPI bi… |
| PRSS12 | Neurotrypsin | Plays a role in neuronal plasticity and the proteolytic action may subserve structural reorganizations associated with learning and memory operations. |
| LHFPL5 | LHFPL tetraspan subfamily member 5 protein | Auxiliary subunit of the mechanotransducer (MET) non-specific cation channel complex located at the tips of the shorter stereocilia of cochlear hair cells and that mediates sensory transduction in the auditory system. |
| EEFSEC | Selenocysteine-specific elongation factor | Translation factor required for the incorporation of the rare amino acid selenocysteine encoded by UGA codons. |
| EEF1D | Elongation factor 1-delta | EF-1-beta and EF-1-delta stimulate the exchange of GDP bound to EF-1-alpha to GTP, regenerating EF-1-alpha for another round of transfer of aminoacyl-tRNAs to the ribosome. |
Protein-family classification
Druggable: 14 · Difficult: 7 · Unknown: 30 · Druggable fraction: 0.27
Family distribution
Cohort families vs a genome-wide background (hypergeometric, BH-FDR; fold = observed/expected). Counts kept; sorted by enrichment, so the catch-all Other/Unknown bucket no longer leads.
| Family | Genes | Fold | FDR |
|---|---|---|---|
| Enzyme (other) | 11 | 2.6× | 0.019 |
| Transporter | 1 | 1.5× | 0.952 |
| Other/Unknown | 30 | 1.1× | 0.952 |
| Transcription factor | 6 | 1.0× | 0.952 |
| Protease | 1 | 0.7× | 0.952 |
| Kinase | 1 | 0.5× | 0.952 |
| Scaffold/PPI | 1 | 0.3× | 0.952 |
Per-gene assignment
| Symbol | Family | Druggable? | EC | InterPro (top 3) |
|---|---|---|---|---|
| NSUN2 | Enzyme (other) | yes | 2.1.1.202 | MeTrfase_RsmB-F_NOP2_dom, RCMT, RCMT_NCL1 |
| CC2D1A | Other/Unknown | no | C2_dom, CC2D1A/B_DM14, C2_domain_sf | |
| TRAPPC9 | Other/Unknown | no | Trs120_TRAPPC9, Trs120_TRAPPC9_N, TPR_TRAPPC9_Trs120 | |
| CLIP1 | Transcription factor | no | CAP-Gly_domain, CLIP1_ZNF, CAP-Gly_dom_sf | |
| SARS1 | Enzyme (other) | yes | 6.1.1.11 | aa-tRNA-synt_IIb, Ser-tRNA-ligase_type_1, aa-tRNA-synth_II |
| AIMP1 | Other/Unknown | no | tRNA-bd_dom, NA-bd_OB-fold, | |
| ST3GAL3 | Enzyme (other) | yes | 2.4.99.2 | Glyco_trans_29, Sialyl_trans, GT29-like_sf |
| SLC12A2 | Other/Unknown | no | SLC12A1/SLC12A2, NKCC1, AA-permease/SLC12A_dom | |
| UBE4A | Transcription factor | no | 2.3.2.27 | Ubox_domain, Znf_RING/FYVE/PHD, Ub_conjug_fac_E4_core |
| EZR | Other/Unknown | no | FERM_domain, Ez/rad/moesin-like, Moesin_tail_sf | |
| FBXO5 | Other/Unknown | no | F-box_dom, ZF_ZBR, FBX5_43 | |
| FRRS1L | Other/Unknown | no | DOMON_domain, FRRS1L | |
| FMN2 | Other/Unknown | no | DEP_dom, FH2_Formin, FH2_Formin_sf | |
| MBOAT7 | Enzyme (other) | yes | 2.3.1.B46 | MBOAT_fam, LPLAT_7/PORCN-like |
| FBXO31 | Other/Unknown | no | F-box_dom, F-box-like_dom_sf, FBXO31/39 | |
| NCDN | Other/Unknown | no | Neurochondrin, ARM-type_fold | |
| SLC45A1 | Transporter | yes | MFS, MFS_trans_sf | |
| KDM5B | Transcription factor | no | 1.14.11.67 | ARID_dom, Znf_PHD, JmjC_dom |
| LMAN2L | Other/Unknown | no | Lectin_leg, ConA-like_dom_sf, Intracellular_Lectin-GPT | |
| TTC5 | Other/Unknown | no | TPR-like_helical_dom_sf, TPR_rpt, TTC5_OB | |
| ZC3H14 | Transcription factor | no | Znf_CCCH, Nab2/ZC3H14 | |
| CRADD | Other/Unknown | no | Death_dom, CARD, DEATH-like_dom_sf | |
| MED23 | Other/Unknown | no | Mediator_Med23 | |
| RSRC1 | Transcription factor | no | SRRP53 | |
| ALKBH8 | Enzyme (other) | yes | 2.1.1.229 | RRM_dom, Oxoglu/Fe-dep_dioxygenase_dom, Nucleotide-bd_a/b_plait_sf |
| MED9 | Other/Unknown | no | Med9, Med7/Med21-like, MED9_metazoa | |
| UFSP2 | Other/Unknown | no | UFSP1/2_DUB_cat, UFSP2-like_2nd | |
| PGAP1 | Other/Unknown | no | PGAP1-ab_dom-like, AB_hydrolase_fold, PGAP1/BST1 | |
| EDC3 | Other/Unknown | no | YjeF_N_dom, FDF_dom, Lsm14-like_N | |
| METTL23 | Other/Unknown | no | Methyltransf_16, SAM-dependent_MTases_sf | |
| B3GALNT2 | Enzyme (other) | yes | 2.4.1.313 | Glyco_trans_31 |
| MED25 | Other/Unknown | no | Med25_PTOV, Mediator_Med25_SD1, Mediator_Med25_VWA | |
| IQSEC1 | Scaffold/PPI | no | Sec7_dom, PH_domain, PH-like_dom_sf | |
| WASHC4 | Other/Unknown | no | WASH7, WASH-4_N, WASH-7_central | |
| DCPS | Enzyme (other) | yes | 3.6.1.59 | DcpS/DCS2, Scavenger_mRNA_decap_enz_N, Histidine_triad_CS |
| CRBN | Other/Unknown | no | Lon_prtase_N, Yippee/Mis18/Cereblon, PUA-like_sf | |
| TUSC3 | Other/Unknown | no | MAGT1/OST3/OST6, Thioredoxin-like_sf | |
| TNIK | Kinase | yes | Prot_kinase_dom, CNH_dom, Ser/Thr_kinase_AS | |
| LINS1 | Other/Unknown | no | Protein_Lines, Lines_C, LINES_N | |
| TECR | Enzyme (other) | yes | 1.3.1.93 | 3-oxo-5_a-steroid_4-DH_C, Ubiquitin-like_domsf, SRD5A/TECR |
| GRIK2 | Other/Unknown | no | Iontro_rcpt_C, Iono_Glu_rcpt_met, ANF_lig-bd_rcpt | |
| HNMT | Enzyme (other) | yes | 2.1.1.8 | HHMT-like, SAM-dependent_MTases_sf |
| MAN1B1 | Enzyme (other) | yes | 3.2.1.113 | Glyco_hydro_47, 6hp_glycosidase-like_sf, Seven-hairpin_glycosidases |
| NDST1 | Enzyme (other) | yes | 2.8.2.8 | Sulfotransferase_dom, Heparan_SO4_deacetylase_dom, P-loop_NTPase |
| PIGC | Other/Unknown | no | Plno_GlcNAc_GPI2 | |
| PRSS12 | Protease | yes | Kringle, SRCR, Trypsin_dom | |
| ZFTRAF1 | Transcription factor | no | Znf_TRAF, Znf_RING, Znf_RING/FYVE/PHD | |
| LHFPL5 | Other/Unknown | no | LHFPL | |
| EEFSEC | Other/Unknown | no | T_Tr_GTP-bd_dom, EFTu-like_2, Transl_B-barrel_sf | |
| MROH6 | Other/Unknown | no | ARM-like, ARM-type_fold, Maestro_heat-like_prot |
Expression context
Cohort genes with no expression data: 0.
46 cohort genes are a single-cell marker in ≥1 SCXA experiment.
Breadth distribution (Bgee present_calls)
| Bucket | Genes |
|---|---|
| narrow (1-5 tissues) | 0 |
| moderate (6-20) | 0 |
| broad (>20) | 51 |
| unknown | 0 |
Top tissues across cohort
| Tissue | Cohort genes |
|---|---|
| calcaneal tendon | 9 |
| secondary oocyte | 5 |
| cerebellar hemisphere | 5 |
| right hemisphere of cerebellum | 5 |
| apex of heart | 5 |
| cortical plate | 5 |
| male germ line stem cell (sensu Vertebrata) in testis | 4 |
| left testis | 4 |
| stromal cell of endometrium | 4 |
| gastrocnemius | 3 |
| hindlimb stylopod muscle | 3 |
| body of pancreas | 3 |
| Brodmann (1909) area 23 | 3 |
| oocyte | 3 |
| right testis | 3 |
| heart left ventricle | 3 |
| right uterine tube | 2 |
| mucosa of transverse colon | 2 |
| islet of Langerhans | 2 |
| tendon | 2 |
Per-gene tissue summary (top 30)
| Symbol | Bgee breadth | FANTOM5 breadth | SCXA | Top tissues |
|---|---|---|---|---|
| NSUN2 | 260 | ubiquitous | marker | upper arm skin, right uterine tube, secondary oocyte |
| CC2D1A | 134 | ubiquitous | marker | right hemisphere of cerebellum, mucosa of transverse colon, cerebellar hemisphere |
| TRAPPC9 | 258 | ubiquitous | marker | hindlimb stylopod muscle, gastrocnemius, apex of heart |
| CLIP1 | 299 | ubiquitous | marker | biceps brachii, buccal mucosa cell, skeletal muscle tissue of rectus abdominis |
| SARS1 | 291 | ubiquitous | marker | islet of Langerhans, body of pancreas, frontal pole |
| AIMP1 | 295 | ubiquitous | marker | calcaneal tendon, rectum, tendon |
| ST3GAL3 | 178 | ubiquitous | marker | hindlimb stylopod muscle, gastrocnemius, muscle of leg |
| SLC12A2 | 277 | ubiquitous | marker | palpebral conjunctiva, parotid gland, inferior vagus X ganglion |
| UBE4A | 298 | ubiquitous | marker | endothelial cell, Brodmann (1909) area 23, middle temporal gyrus |
| EZR | 291 | ubiquitous | marker | ventricular zone, bronchial epithelial cell, epithelium of bronchus |
| FBXO5 | 225 | ubiquitous | marker | ventricular zone, ganglionic eminence, secondary oocyte |
| FRRS1L | 189 | broad | marker | middle temporal gyrus, Brodmann (1909) area 23, orbitofrontal cortex |
| FMN2 | 187 | broad | marker | cortical plate, prefrontal cortex, Brodmann (1909) area 9 |
| MBOAT7 | 141 | ubiquitous | marker | blood, right adrenal gland, right adrenal gland cortex |
| FBXO31 | 261 | ubiquitous | marker | cerebellar hemisphere, cerebellar cortex, right hemisphere of cerebellum |
| NCDN | 208 | ubiquitous | marker | middle frontal gyrus, Brodmann (1909) area 10, nucleus accumbens |
| SLC45A1 | 167 | ubiquitous | yes | male germ line stem cell (sensu Vertebrata) in testis, primordial germ cell in gonad, prefrontal cortex |
| KDM5B | 272 | ubiquitous | marker | sperm, male germ cell, left testis |
| LMAN2L | 267 | ubiquitous | marker | islet of Langerhans, renal medulla, ovary |
| TTC5 | 227 | ubiquitous | marker | secondary oocyte, oocyte, primordial germ cell in gonad |
| ZC3H14 | 298 | ubiquitous | marker | left testis, right testis, sperm |
| CRADD | 260 | ubiquitous | marker | male germ line stem cell (sensu Vertebrata) in testis, heart left ventricle, cardiac ventricle |
| MED23 | 283 | ubiquitous | yes | right hemisphere of cerebellum, calcaneal tendon, cerebellar hemisphere |
| RSRC1 | 264 | ubiquitous | marker | calcaneal tendon, sural nerve, tendon |
| ALKBH8 | 226 | ubiquitous | marker | calcaneal tendon, male germ line stem cell (sensu Vertebrata) in testis, cortical plate |
| MED9 | 195 | ubiquitous | marker | apex of heart, heart left ventricle, cardiac ventricle |
| UFSP2 | 290 | ubiquitous | marker | calcaneal tendon, hindlimb stylopod muscle, triceps brachii |
| PGAP1 | 271 | ubiquitous | marker | endothelial cell, ganglionic eminence, upper leg skin |
| EDC3 | 204 | ubiquitous | marker | left testis, right testis, cortical plate |
| METTL23 | 256 | ubiquitous | marker | kidney epithelium, epithelial cell of pancreas, left ventricle myocardium |
Protein interactions among cohort
Intra-cohort edges: 11.
Hub genes (top 10 by interactor count)
| Symbol | Interactor count |
|---|---|
| EZR | 4,626 |
| AIMP1 | 3,917 |
| EEF1D | 3,866 |
| KDM5B | 3,722 |
| RSRC1 | 3,518 |
| NSUN2 | 3,213 |
| TTC5 | 2,981 |
| FBXO5 | 2,844 |
| EDC3 | 2,714 |
| ZC3H14 | 2,613 |
Intra-cohort edges
| A | B | Sources |
|---|---|---|
| CC2D1A | CRBN | string_interaction |
| CC2D1A | PRSS12 | string_interaction |
| CRBN | PRSS12 | string_interaction |
| DCPS | EDC3 | string_interaction |
| EEFSEC | SARS1 | string_interaction |
| EZR | SLC12A2 | intact |
| EZR | TNIK | intact |
| FBXO31 | FBXO5 | string_interaction |
| GRIK2 | NCDN | string_interaction |
| MED23 | MED25 | biogrid_interaction, string_interaction |
| PGAP1 | PIGC | string_interaction |
Structural data
PDB: 31 · AlphaFold-only: 20 · No structure: 0
Cohort genes with PDB structures (top 30)
| Symbol | UniProt | PDB entries |
|---|---|---|
| CRBN | Q96SW2 | 90 |
| KDM5B | Q9UGL1 | 56 |
| SLC12A2 | P55011 | 14 |
| MED23 | Q9ULK4 | 13 |
| CLIP1 | P30622 | 11 |
| MED9 | Q9NWA0 | 11 |
| DCPS | Q96C86 | 11 |
| TNIK | Q9UKE5 | 11 |
| MED25 | Q71SY5 | 10 |
| NSUN2 | Q08J23 | 9 |
| SARS1 | P49591 | 9 |
| EZR | P15311 | 7 |
| HNMT | P50135 | 7 |
| AIMP1 | Q12904 | 6 |
| EDC3 | Q96F86 | 6 |
| IQSEC1 | Q6DN90 | 6 |
| MAN1B1 | Q9UKM7 | 6 |
| NDST1 | P52848 | 5 |
| TTC5 | Q8N0Z6 | 4 |
| TUSC3 | Q13454 | 4 |
| EEFSEC | P57772 | 4 |
| EEF1D | P29692 | 4 |
| FBXO5 | Q9UKT4 | 3 |
| CRADD | P78560 | 3 |
| ALKBH8 | Q96BT7 | 3 |
| FMN2 | Q9NZ56 | 2 |
| FBXO31 | Q5XUX0 | 2 |
| GRIK2 | Q13002 | 2 |
| UBE4A | Q14139 | 1 |
| MBOAT7 | Q96N66 | 1 |
AlphaFold-only cohort genes (top 30 by pLDDT)
| Symbol | UniProt | pLDDT |
|---|---|---|
| METTL23 | Q86XA0 | 93.81 |
| UFSP2 | Q9NUQ7 | 91.21 |
| ST3GAL3 | Q11203 | 90.87 |
| PGAP1 | Q75T13 | 89.15 |
| LHFPL5 | Q8TAF8 | 89.11 |
| PIGC | Q92535 | 88.98 |
| NCDN | Q9UBB6 | 88.12 |
| B3GALNT2 | Q8NCR0 | 86.81 |
| LMAN2L | Q9H0V9 | 84.90 |
| WASHC4 | Q2M389 | 83.82 |
| TRAPPC9 | Q96Q05 | 82.98 |
| ZFTRAF1 | P0DTL6 | 82.71 |
| FRRS1L | Q9P0K9 | 80.60 |
| PRSS12 | P56730 | 77.42 |
| MROH6 | A6NGR9 | 76.21 |
| CC2D1A | Q6P1N0 | 74.71 |
| LINS1 | Q8NG48 | 72.44 |
| SLC45A1 | Q9Y2W3 | 66.26 |
| RSRC1 | Q96IZ7 | 58.46 |
| ZC3H14 | Q6PJT7 | 56.87 |
Function
Pathway analysis
Distinct Reactome pathways touched by cohort: 136. Enrichment computed across 51 evidence-associated genes (37 with Reactome annotation).
Pathways by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 37 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| Pathway | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| Maturation of spike protein | 3 | 21.5× | 0.027 | ST3GAL3, TUSC3, MAN1B1 |
| Selenoamino acid metabolism | 3 | 16.0× | 0.027 | SARS1, AIMP1, EEFSEC |
| Respiratory Syncytial Virus Infection Pathway | 3 | 16.0× | 0.027 | MED23, MED9, MED25 |
| Metabolism of lipids | 6 | 5.1× | 0.027 | ST3GAL3, MBOAT7, MED23, MED9, MED25, TECR |
| Metabolism | 10 | 3.1× | 0.027 | SARS1, AIMP1, ST3GAL3, MBOAT7, MED23, EEFSEC, MED9, MED25 (+2 more) |
| Maternal to zygotic transition (MZT) | 2 | 38.6× | 0.027 | KDM5B, METTL23 |
| RSV-host interactions | 3 | 12.7× | 0.028 | MED23, MED9, MED25 |
| Adipogenesis | 3 | 12.7× | 0.028 | MED23, MED9, MED25 |
| Defective MAN1B1 causes MRT15 | 1 | 308.6× | 0.034 | MAN1B1 |
| Cytosolic tRNA aminoacylation | 2 | 23.7× | 0.034 | SARS1, AIMP1 |
| Regulation of lipid metabolism by PPARalpha | 3 | 11.4× | 0.034 | MED23, MED9, MED25 |
| Transcriptional regulation of white adipocyte differentiation | 3 | 10.5× | 0.034 | MED23, MED9, MED25 |
| Asparagine N-linked glycosylation | 4 | 6.5× | 0.034 | ST3GAL3, LMAN2L, TUSC3, MAN1B1 |
| Translation of Structural Proteins | 2 | 22.1× | 0.036 | ST3GAL3, MAN1B1 |
| Activation of Na-permeable kainate receptors | 1 | 154.3× | 0.050 | GRIK2 |
| tRNA modification in the nucleus and cytosol | 2 | 15.8× | 0.050 | NSUN2, ALKBH8 |
| Late SARS-CoV-2 Infection Events | 2 | 15.8× | 0.050 | ST3GAL3, MAN1B1 |
| tRNA Aminoacylation | 2 | 15.4× | 0.050 | SARS1, AIMP1 |
| PPARA activates gene expression | 3 | 7.7× | 0.050 | MED23, MED9, MED25 |
| Viral Infection Pathways | 5 | 4.2× | 0.050 | ST3GAL3, MED23, MED9, MED25, MAN1B1 |
| Mitotic Metaphase/Anaphase Transition | 1 | 102.9× | 0.063 | FBXO5 |
| Glycosaminoglycan metabolism | 2 | 11.9× | 0.076 | ST3GAL3, NDST1 |
| Sensory processing of sound by outer hair cells of the cochlea | 2 | 11.0× | 0.083 | EZR, LHFPL5 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | 1 | 61.7× | 0.088 | KDM5B |
| Infectious disease | 5 | 3.4× | 0.088 | ST3GAL3, MED23, MED9, MED25, MAN1B1 |
| Metabolism of amino acids and derivatives | 3 | 5.5× | 0.090 | SARS1, AIMP1, EEFSEC |
| DAG1 core M3 glycosylations | 1 | 51.4× | 0.095 | B3GALNT2 |
| Cation-coupled Chloride cotransporters | 1 | 44.1× | 0.095 | SLC12A2 |
| Signaling by LTK in cancer | 1 | 44.1× | 0.095 | CLIP1 |
| COPII-mediated vesicle transport | 2 | 8.8× | 0.095 | TRAPPC9, LMAN2L |
GO biological processes by enrichment
Over-representation of cohort genes vs the genome-wide background (hypergeometric test, Benjamini-Hochberg FDR; fold = observed/expected over 49 annotated cohort genes). Counts and members are kept as ground-truth; sorted by enrichment.
| GO term | Cohort genes | Fold | FDR | Sample cohort genes |
|---|---|---|---|---|
| cognition | 4 | 23.3× | 0.008 | METTL23, WASHC4, TUSC3, LINS1 |
| selenocysteine incorporation | 2 | 76.4× | 0.032 | SARS1, EEFSEC |
| DNA damage response | 6 | 6.5× | 0.032 | FBXO5, FMN2, FBXO31, TTC5, CRADD, ALKBH8 |
| positive regulation of transcription elongation by RNA polymerase II | 3 | 18.4× | 0.043 | MED23, MED9, MED25 |
| RNA polymerase II preinitiation complex assembly | 3 | 16.6× | 0.043 | MED23, MED9, MED25 |
| positive regulation of transcription initiation by RNA polymerase II | 3 | 16.6× | 0.043 | MED23, MED9, MED25 |
| histamine catabolic process | 1 | 343.9× | 0.047 | HNMT |
| meiotic cell cycle checkpoint signaling | 1 | 343.9× | 0.047 | NSUN2 |
| protein alpha-1,2-demannosylation | 1 | 343.9× | 0.047 | MAN1B1 |
| positive regulation of cell volume | 1 | 343.9× | 0.047 | SLC12A2 |
| homologous chromosome movement towards spindle pole in meiosis I anaphase | 1 | 343.9× | 0.047 | FMN2 |
| detection of cold stimulus involved in thermoception | 1 | 343.9× | 0.047 | GRIK2 |
| nuclear envelope budding | 1 | 343.9× | 0.047 | WASHC4 |
| endolysosomal toll-like receptor signaling pathway | 1 | 343.9× | 0.047 | WASHC4 |
| apical dendrite arborization | 1 | 343.9× | 0.047 | CC2D1A |
| negative regulation of vascular endothelial growth factor production | 1 | 343.9× | 0.047 | SARS1 |
| negative regulation of snRNA transcription by RNA polymerase II | 1 | 343.9× | 0.047 | CC2D1A |
| regulation of estradiol secretion | 1 | 343.9× | 0.047 | KDM5B |
| positive regulation of mediator complex assembly | 1 | 343.9× | 0.047 | MED25 |
| respiratory gaseous exchange by respiratory system | 2 | 25.5× | 0.047 | HNMT, NDST1 |
| tRNA modification | 2 | 24.6× | 0.047 | NSUN2, SARS1 |
| tRNA methylation | 2 | 23.7× | 0.048 | NSUN2, ALKBH8 |
| actin cytoskeleton organization | 4 | 6.5× | 0.048 | EZR, FMN2, IQSEC1, TNIK |
| viral protein processing | 2 | 22.2× | 0.050 | ST3GAL3, MAN1B1 |
| cytoplasmic translational elongation | 1 | 172.0× | 0.057 | EEF1D |
| seryl-tRNA aminoacylation | 1 | 172.0× | 0.057 | SARS1 |
| negative regulation of DNA endoreduplication | 1 | 172.0× | 0.057 | FBXO5 |
| positive regulation of glucagon secretion | 1 | 172.0× | 0.057 | AIMP1 |
| inorganic anion import across plasma membrane | 1 | 172.0× | 0.057 | SLC12A2 |
| inorganic cation import across plasma membrane | 1 | 172.0× | 0.057 | SLC12A2 |
Therapeutics
Drug target analysis
Approved (phase 4): 4 · Phase ≥3: 6 · Phased (≥1): 10 · Undrugged: 41
Druggability breadth: 22 of 51 evidence-associated genes (43%) have a ChEMBL target (buckets above are over the deeply-mined display cohort).
Genes with an approved drug
The molecule shown is one approved compound that hits the gene — not necessarily a drug of choice or one indicated for this disease.
| Symbol | Example approved molecule |
|---|---|
| SLC12A2 | BUMETANIDE |
| MED23 | PALBOCICLIB |
| CRBN | DASABUVIR |
| TNIK | PONATINIB |
Top cohort targets by molecule count
| Symbol | Molecules | Max phase |
|---|---|---|
| TNIK | 46 | 4 |
| CRBN | 18 | 4 |
| KDM5B | 2 | 3 |
| GRIK2 | 2 | 3 |
| NSUN2 | 1 | 2 |
| SLC12A2 | 1 | 4 |
| NCDN | 1 | 2 |
| MED23 | 1 | 4 |
| TECR | 1 | 2 |
| EEF1D | 1 | 2 |
Drugs targeting cohort genes (top 30)
| Molecule | Max phase | Targets in cohort |
|---|---|---|
| BUMETANIDE | 4 | SLC12A2 |
| PALBOCICLIB | 4 | MED23 |
| DASABUVIR | 4 | CRBN |
| POMALIDOMIDE | 4 | CRBN |
| THALIDOMIDE | 4 | CRBN |
| LENALIDOMIDE | 4 | CRBN |
| PONATINIB | 4 | CRBN, TNIK |
| ASCIMINIB | 4 | CRBN |
| BRIGATINIB | 4 | CRBN |
| CRIZOTINIB | 4 | CRBN |
| LENVATINIB | 4 | TNIK |
| AXITINIB | 4 | TNIK |
| SORAFENIB | 4 | TNIK |
| NERATINIB | 4 | TNIK |
| PACRITINIB | 4 | TNIK |
| VANDETANIB | 4 | TNIK |
| BOSUTINIB | 4 | TNIK |
| PAZOPANIB | 4 | TNIK |
| NINTEDANIB | 4 | TNIK |
| SUNITINIB | 4 | TNIK |
| DASATINIB | 4 | TNIK |
| ERLOTINIB | 4 | TNIK |
| QUIZARTINIB | 4 | TNIK |
| MIDOSTAURIN | 4 | TNIK |
| GEFITINIB | 4 | TNIK |
| CAFFEIC ACID | 3 | KDM5B |
| EBSELEN | 3 | KDM5B |
| IBERDOMIDE | 3 | CRBN |
| URACIL | 3 | CRBN |
| VEPDEGESTRANT | 3 | CRBN |
Bioactivity and enzyme data
Enzyme cohort genes (≥1 EC): 13.
Cohort genes with ChEMBL bioactivity (full, sorted by assay count)
| Symbol | Assays | Type breakdown |
|---|---|---|
| CRBN | 5,948 | Binding:5779, Functional:154, ADMET:15 |
| TNIK | 257 | Binding:257 |
| KDM5B | 146 | Binding:146 |
| GRIK2 | 92 | Binding:66, Functional:26 |
| DCPS | 23 | Binding:20, ADMET:3 |
| SLC12A2 | 13 | Binding:9, Functional:4 |
| NSUN2 | 11 | Binding:11 |
| MED23 | 9 | Binding:9 |
| HNMT | 9 | Binding:7, ADMET:2 |
| EEF1D | 8 | Binding:8 |
| NCDN | 7 | Binding:7 |
| TECR | 7 | Binding:7 |
| EZR | 4 | Binding:4 |
| MED25 | 3 | Binding:3 |
| SARS1 | 2 | ADMET:1, Binding:1 |
| AIMP1 | 2 | Binding:2 |
| ST3GAL3 | 2 | Binding:2 |
| UBE4A | 1 | Binding:1 |
| MBOAT7 | 1 | Binding:1 |
| WASHC4 | 1 | Binding:1 |
| MAN1B1 | 1 | Binding:1 |
| PRSS12 | 1 | Binding:1 |
Cohort enzymes (BRENDA EC)
| Symbol | EC numbers | Names |
|---|---|---|
| NSUN2 | 2.1.1.202, 2.1.1.203 | multisite-specific tRNA:(cytosine-C5)-methyltransferase, tRNA (cytosine34-C5)-methyltransferase |
| SARS1 | 6.1.1.11 | serine-tRNA ligase |
| ST3GAL3 | 2.4.99.2, 2.4.99.6 | beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminide alpha-2,3-sialyltransferase, N-acetyllactosaminide alpha-2,3-sialyltransferase |
| UBE4A | 2.3.2.27, 2.3.2.B12 | RING-type E3 ubiquitin transferase, |
| MBOAT7 | 2.3.1.B46 | |
| KDM5B | 1.14.11.67 | [histone H3]-trimethyl-L-lysine4 demethylase |
| ALKBH8 | 2.1.1.229 | tRNA (carboxymethyluridine34-5-O)-methyltransferase |
| B3GALNT2 | 2.4.1.313 | protein O-mannose beta-1,3-N-acetylgalactosaminyltransferase |
| DCPS | 3.6.1.59 | 5’-(N7-methyl 5’-triphosphoguanosine)-[mRNA] diphosphatase |
| TECR | 1.3.1.93 | very-long-chain enoyl-CoA reductase |
| HNMT | 2.1.1.8 | histamine N-methyltransferase |
| MAN1B1 | 3.2.1.113, 3.2.1.209 | mannosyl-oligosaccharide 1,2-alpha-mannosidase, endoplasmic reticulum Man9GlcNAc2 1,2-alpha-mannosidase |
| NDST1 | 2.8.2.8 | [heparan sulfate]-glucosamine N-sulfotransferase |
Cohort genes with high screening signal
≥100 ChEMBL assays — a studied-ness signal; see Therapeutics for approved-drug status.
| Symbol | ChEMBL assays |
|---|---|
| KDM5B | 146 |
| CRBN | 5,948 |
| TNIK | 257 |
Pharmacogenomics
Cohort genes with a PharmGKB record: 51; with CPIC/DPWG dosing guidelines: 0.
No cohort gene has a CPIC/DPWG genotype-guided dosing guideline (PharmGKB).
Chemical tractability of cohort targets
30 approved/phased compounds have measured bioactivity against a cohort gene (and aren’t yet in disease-level trials). This is a research / tractability signal, NOT a therapeutic recommendation — a bioactivity row often reflects off-target or screening binding (e.g. promiscuous kinase inhibitors against a cohort kinase), implying no disease mechanism.
| Compound | Max phase | Cohort target (bioactivity) |
|---|---|---|
| BUMETANIDE | 4 | SLC12A2 |
| PALBOCICLIB | 4 | MED23 |
| DASABUVIR | 4 | CRBN |
| POMALIDOMIDE | 4 | CRBN |
| THALIDOMIDE | 4 | CRBN |
| LENALIDOMIDE | 4 | CRBN |
| PONATINIB | 4 | CRBN, TNIK |
| ASCIMINIB | 4 | CRBN |
| BRIGATINIB | 4 | CRBN |
| CRIZOTINIB | 4 | CRBN |
| LENVATINIB | 4 | TNIK |
| AXITINIB | 4 | TNIK |
| SORAFENIB | 4 | TNIK |
| NERATINIB | 4 | TNIK |
| PACRITINIB | 4 | TNIK |
| VANDETANIB | 4 | TNIK |
| BOSUTINIB | 4 | TNIK |
| PAZOPANIB | 4 | TNIK |
| NINTEDANIB | 4 | TNIK |
| SUNITINIB | 4 | TNIK |
| DASATINIB | 4 | TNIK |
| ERLOTINIB | 4 | TNIK |
| QUIZARTINIB | 4 | TNIK |
| MIDOSTAURIN | 4 | TNIK |
| GEFITINIB | 4 | TNIK |
| CAFFEIC ACID | 3 | KDM5B |
| EBSELEN | 3 | KDM5B |
| IBERDOMIDE | 3 | CRBN |
| URACIL | 3 | CRBN |
| VEPDEGESTRANT | 3 | CRBN |
Druggability pyramid
Cohort genes binned by druggability tier (high → low):
| Tier | Definition | Genes | Symbols |
|---|---|---|---|
| A | Approved (phase 4 drug) | 4 | SLC12A2, MED23, CRBN, TNIK |
| B | Phased (≥1) drug, not yet approved | 6 | NSUN2, NCDN, KDM5B, TECR, GRIK2, EEF1D |
| C | Druggable family + PDB, no drug | 7 | SARS1, MBOAT7, ALKBH8, DCPS, HNMT, MAN1B1, NDST1 |
| D | Druggable family + AlphaFold only, no drug | 4 | ST3GAL3, SLC45A1, B3GALNT2, PRSS12 |
| E | Difficult family or no structure, no drug | 30 | CC2D1A, TRAPPC9, CLIP1, AIMP1, UBE4A, EZR, FBXO5, FRRS1L, FMN2, FBXO31 (+20 more) |
Undrugged target profiles
41 cohort genes are undrugged. Ranked by ‘starting-point quality’ (assay depth + drugged-partner adjacency).
| Symbol | ChEMBL assays | Drugged partners (top 3) |
|---|---|---|
| CC2D1A | 0 | CRBN |
| MED25 | 3 | MED23 |
| PRSS12 | 1 | CRBN |
| TRAPPC9 | 0 | — |
| CLIP1 | 0 | — |
| SARS1 | 2 | — |
| AIMP1 | 2 | — |
| ST3GAL3 | 2 | — |
| UBE4A | 1 | — |
| EZR | 4 | — |
| FBXO5 | 0 | — |
| FRRS1L | 0 | — |
| FMN2 | 0 | — |
| MBOAT7 | 1 | — |
| FBXO31 | 0 | — |
| SLC45A1 | 0 | — |
| LMAN2L | 0 | — |
| TTC5 | 0 | — |
| ZC3H14 | 0 | — |
| CRADD | 0 | — |
| RSRC1 | 0 | — |
| ALKBH8 | 0 | — |
| MED9 | 0 | — |
| UFSP2 | 0 | — |
| PGAP1 | 0 | — |
| EDC3 | 0 | — |
| METTL23 | 0 | — |
| B3GALNT2 | 0 | — |
| IQSEC1 | 0 | — |
| WASHC4 | 1 | — |
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
- Cohort genes: NSUN2, CC2D1A, TRAPPC9, CLIP1, SARS1, AIMP1, ST3GAL3, SLC12A2, UBE4A, EZR, FBXO5, FRRS1L, FMN2, MBOAT7, FBXO31, NCDN, SLC45A1, KDM5B, LMAN2L, TTC5, ZC3H14, CRADD, MED23, RSRC1, ALKBH8, MED9, UFSP2, PGAP1, EDC3, METTL23, B3GALNT2, MED25, IQSEC1, WASHC4, DCPS, CRBN, TUSC3, TNIK, LINS1, TECR, GRIK2, HNMT, MAN1B1, NDST1, PIGC, PRSS12, ZFTRAF1, LHFPL5, EEFSEC, MROH6, EEF1D